The clinical significance of immunosuppression in ovarian cancer microenvironments

2021/41/N/NZ6/01727

Keywords

Descriptors

  • NZ6_002: Immunologia kliniczna

Panel

NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution

Uniwersytet Medyczny w Lublinie

Voivodeship: lubelskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Anna Maria Pawłowska-Łachut

Number of co-investigators in the project: 3

Call

PRELUDIUM 20 – announced on 2021-03-15

Amount awarded
209 870 PLN
Project start date
2022-02-01
Project end date
2027-01-31
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (2)

  1. The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients

    Authors:
    Pawłowska Anna, Wiktoria Skiba, Dorota Suszczyk, Weronika Kuryło, Joanna Jakubowicz-Gil, Roman Paduch, Iwona Wertel
    Academic press:
    Cancers (year: 2022, volume: 14, pages: 5757), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers14235757 – link to the publication
  2. Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors

    Authors:
    Anna Pawłowska , Anna Rekowska, Weronika Kuryło, Anna Pańczyszyn, Jan Kotarski, Iwona Wertel
    Academic press:
    International Journal of Molecular Sciences (year: 2023, volume: 24, pages: 10859), Publisher: Multidisciplinary Digital Publishing Institute
    Status:
    Published
    DOI:
    10.3390/ijms241310859 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski